Hot Pursuit     15-Jun-23
Biocon Ltd spurts 1.4%, rises for third straight session
Biocon Ltd is quoting at Rs 242.7, up 1.4% on the day as on 12:49 IST on the NSE. The stock is down 24.57% in last one year as compared to a 21.97% jump in NIFTY and a 9.04% jump in the Nifty Metal index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 242.7, up 1.4% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.11% on the day, quoting at 18735.35. The Sensex is at 63112.59, down 0.18%. Biocon Ltd has slipped around 1.44% in last one month.

Meanwhile, Nifty Metal index of which Biocon Ltd is a constituent, has slipped around 5.64% in last one month and is currently quoting at 12976.8, up 1.39% on the day. The volume in the stock stood at 19.9 lakh shares today, compared to the daily average of 34.56 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 243.8, up 1.33% on the day. Biocon Ltd is down 24.57% in last one year as compared to a 21.97% jump in NIFTY and a 9.04% jump in the Nifty Metal index.

The PE of the stock is 275 based on TTM earnings ending March 23.

Previous News
  Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules
 ( Hot Pursuit - 22-Apr-24   11:39 )
  Biocon gains after subsidiary secures 'Yesafili' entry into Canadian market
 ( Hot Pursuit - 04-Mar-24   11:42 )
  Biocon Biologics divests its non-crore branded formulations biz in India
 ( Corporate News - 10-Nov-23   12:06 )
  Board of Biocon recommends final dividend
 ( Corporate News - 16-May-24   17:54 )
  Board of Biocon appoints director
 ( Corporate News - 27-Jul-23   12:46 )
  Biocon to hold board meeting
 ( Corporate News - 11-Apr-24   16:18 )
  Biocon consolidated net profit rises 71.09% in the June 2022 quarter
 ( Results - Announcements 28-Jul-22   08:19 )
  Biocon subsidiary launches biosimilar for Humira in US
 ( Hot Pursuit - 04-Jul-23   08:56 )
  Biocon Ltd spurts 0.7%, gains for fifth straight session
 ( Hot Pursuit - 03-Oct-22   13:00 )
  Biocon records PAT of Rs 101 crore in Q1; EBITDA margin at 23%
 ( Hot Pursuit - 11-Aug-23   11:13 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top